Revenue | $10 - $100 million See Exact Annual Revenue |
---|---|
Employees | 100 - 500Exact Company Size |
Primary Industry | 5417 Scientific Research & Development Services |
Address | 1111 Kane Concourse Suite 301 Bay Harbor Islands, FL 33154 |
Fortress Biotech | Revenue Est. ($ Million) | Growth Rate (%) | # Employees |
---|---|---|---|
2023 | $10 - $100 million Details in Premium Report | ||
2022 | |||
2021 | |||
2020 | |||
2019 |
1-Year Growth Rate: 3-Year Growth Rate (CAGR): |
Fortress Biotech P&L | $ Millions |
---|---|
Revenue (Sales) | |
Cost of Goods Sold | |
Gross Profit | |
Operating Expenses | |
Advertising | |
Salaries and wages | |
Other Operating Expenses | |
Total Operating Expenses | |
Operating Income | |
EBITDA | |
EBIT (Earnings Before Interest and Taxes) | |
Net Profit | |
Trademark | Date |
---|---|
FORTRESS BIOTECH Medical, biological and pharmaceutical preparations for scientific, research, medical or pharmaceutical use, namely, preparations for the treatment of cancer, autoimmune diseases and disorder, rare diseases, genetic diseases, infectious diseases, central nervous system infections, gastrointestinal infections, genitourinary infections, ocular infections, dermatological infections, immune system infections, liver infections, hepatic infections, neurological disorders, tuberculosis, lung diseases, asthma, hypertension, cardiovascular diseases, immunologic diseases, immunologic deficiency syndromes, tumors, proliferative diseases, inflammatory diseases, inflammatory bowel diseases, inflammatory connective tissue diseases, psoriasis, ophthalmologic diseases, fibrotic diseases, metabolic diseases, dental and oral diseases, neurological diseases, Alzheimer¿s disease, Huntington¿s disease, Parkinson, cerebral palsy, brain injury, spinal cord injury, seizure disorders, congenital disorders, metabolic disorders, viral and infectious diseases and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of genetic and congenital disorders, metabolic disorders, infectious diseases, cancer and pain relief; Pharmaceutical products for the treatment and normalization of disorders of the body's circulatory system; Pharmaceutical products for the treatment of diseases of the blood or of the lymphatic circulatory system; Pharmaceutical preparations for the purpose of increasing the effectiveness of other pharmaceutical products; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals | 04/08/2015 |
INNMUNE Pharmaceutical products for the prevention and treatment of cancer | 09/04/2009 |
CORONADO BIOSCIENCES PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CANCER, AUTOIMMUNE DISORDERS, INFLAMMATORY CONDITIONS, ALLERGIC CONDITIONS AND PROLIFERATIVE DISORDERS | 08/31/2007 |
Company | Headquarters | Revenue ($ MM) |
---|---|---|
LEIDOS | Denver, CO | 100 |
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA | Albuquerque, NM | 30 |
INC RESEARCH | Raleigh, NC | 27 |
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK | Albany, NY | 17 |
FLUOR MARINE PROPULSION | West Mifflin, PA | 15 |
SYNEOS HEALTH | Raleigh, NC | 13 |
ILLUMINA | San Diego, CA | 12 |
UT-BATTELLE | Oak Ridge, TN | 11 |
PRA HOLDINGS | Raleigh, NC | 11 |
Company | Headquarters | Revenue ($ MM) |
---|---|---|
OPKO HEALTH | Miami, FL | 100 |
BIOTISSUE OCULAR | Miami, FL | 9 |
FORTRESS BIOTECH | Bay Harbor Islands, FL | 6 |
FLORIDA MEDICAL CENTER GROUP | Miami, FL | 3 |
QPS MRA | Miami, FL | 3 |
PREMIER CLINICAL RESEARCH INSTITUTE | Miami, FL | 1 |
Company | Revenue ($ MM) |
---|---|
|